Use of Catridge-based Nuclei Acid Amplification Test (CBNAAT) machines has greatly strengthened the battle against tuberculosis (TB) in India as the country aims to eradicate the killer disease completely by 2025. “CBNAAT has come as a boon for treatment of tuberculosis; and all the districts of Odisha have at least one such machine in place which can diagnose drug resistant TB within a few hours,” Dr Paresh Mohanty, Senior Consultant Microbiologist, Integrated Reference Laboratory (IRL) at the SCB Medical College Hospital, Cuttack, said on Tuesday.
While the World Health Organisation (WHO) had fixed a target to eradicate TB from the face of the earth by 2030, the Central Government was taking steps to wipe out the disease from India five years earlier, Dr Mohanty said while speaking at a Continuing Medical Education (CME) programme organised at the Institute of Medical Sciences and SUM Hospital here. The Central Government was implementing the National Tuberculosis Elimination Programme (NTEP) consolidating a series of rapid and progressive advancements taken up under the earlier Revised National Tuberculosis Control Programme (RNTCP) since January 1, 2020, he said.
Dr Mohanty said that 2.7 million of the world’s 10 million patients live in India of whom 64 per cent received treatment in hospitals and wellness centres in the private sector which significantly contributed to the healthcare service delivery system in the country.“But very little information about TB patients from the private sector facilities are percolating down to the NTEP and the Government is unable to notify those patients. It makes detection of cases at the national level difficult,” Dr Mohanty said.
He said that private sector healthcare institutions can make use of CBNAAT facilities available in public sector hospitals and healthcare centres free of cost which would greatly assist in the ongoing battle against the disease.Medical practitioners are battling disease as delay in diagnosis of drug resistant tuberculosis could result in death. Various forms of drug-resistant TB have emerged over years though several newer drugs like Bedaquiline and Delamanid have been introduced to counter same, he said.